Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
about
The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular CarcinomaEnhanced efficacy with reduced toxicity of chemotherapy drug 5-fluorouracil by synergistic treatment with Abnormal Savda Munziq from Uyghur medicine.Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in InsulinomasCancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrinSurface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC.
P2860
Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
@ast
Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
@en
type
label
Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
@ast
Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
@en
prefLabel
Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
@ast
Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
@en
P2093
P2860
P356
P1433
P1476
Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
@en
P2093
Chien-Yu Cho
Ching-Shih Chen
Hau-Lun Huang
Hui-Ping Hsu
Ming-Derg Lai
Po-Ting Lai
Tzu-Yang Weng
Wei-Ching Chen
Yih-Jyh Lin
Yung-Sheng Chang
P2860
P304
42923-42937
P356
10.18632/ONCOTARGET.5976
P407
P577
2015-10-22T00:00:00Z